Chemo's genetic impact on sperm revealed in new study
NCT ID NCT02975245
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looks at how chemotherapy changes sperm DNA in men with cancer. Researchers collect semen samples before treatment and one week after the first round of chemo. They compare the DNA and quality of the sperm to understand short-term effects. The goal is to learn more about fertility risks for male cancer patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could help doctors understand how chemotherapy affects sperm and inform fertility counseling for male cancer patients.
- What could go wrong
- This is an observational study, not a treatment trial. It only looks at short-term effects and may not predict long-term fertility or genetic risks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Magee-Womens Hospital
Pittsburgh, Pennsylvania, 15213, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A good Night's sleep: could a simple program ease Cancer's toll on rest?
- Could sitting up make radiation therapy more comfortable?
- Can we predict dangerous side effects when combining radiation and immunotherapy?
- Family history as a shield: can culturally tailored guidance cut cancer risk?
- A simple screening program could transform cancer aftercare
- Can simple positive activities boost Well-Being in cancer care?